What smart money is saying about Stevanato Group
4 funds in our archive have pitched Stevanato Group — most recently Riverwater Partners Sustainable Value Strategy in June 2026.
Stevanato Group S.p.A. is dedicated to engineering, manufacturing, and distributing integrated solutions for the pharmaceutical and healthcare sectors. Its core offerings span a wide array of products, including containment solutions, drug delivery systems, and medical devices, alongside diagnostic and analytical support. The company also produces specialized machinery for tasks such as visual inspection, assembly, packaging, and glass formation. Established in 1949, the company's main operations are situated in Piombino Dese, Italy, functioning as a subsidiary of Stevanato Holding S.R.L.
Get an email when a fund writes about it
Position history
Between Q2 2025 and Q2 2026, 2 fund letters reported a position in Stevanato Group — 1 opened or added to the position.
| Quarter | Letters | Bought | Sold | Theses |
|---|---|---|---|---|
| Q2 2026 | 2 | 1 | 0 | 2 |
| Q4 2025 | 0 | 0 | 0 | 1 |
| Q2 2025 | 0 | 0 | 0 | 1 |
Fund activity · 2 positions · 1 move
- New positionRiverwater Partners Small Cap StrategyJune 2026
“In addition, we initiated positions in Stevanato Group (STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries.”
Stevanato Group - June 2026
“Stock selection in Health Care contributed to performance, particularly the fund’s investment in Stevanato Group SpA (STVN), which was up more than 30% in the period.”
Stevanato Group
Also mentioned · 3
These funds discuss Stevanato Group — as a competitor, benchmark or comparable — without disclosing a position in it.
- MentionedTimesSquare U.S. Mid Cap GrowthJune 2026
“Drug-containment solutions supplier Stevanato Group S.p.A. climbed 32% for the quarter.”
Stevanato Group - March 2026
“Stevanato Group supplies drug containment, drug delivery, and diagnostic solutions to the biopharmaceutical industry.”
Stevanato Group - March 2026
“Stevanato Group supplies drug containment, drug delivery, and diagnostic solutions to the biopharmaceutical industry.”
Stevanato Group
Fund coverage · 4 theses
Stevanato Group is a vertically integrated drug containment and delivery supplier with switching costs, family alignment, and an attractive valuation.
Read the full thesisStevanato Group S.p.A. is a leading drug containment and delivery provider, with growth supported by injectables demand and an attractive valuation.
Read the full thesis- Artisan U.S. Small-Cap Growth StrategyDecember 2025
Stevanato Group SpA is a health care packaging and machinery leader positioned to benefit from liquid biologics growth and broader GLP-1 coverage despite near-term uncertainty.
Read the full thesis - Artisan US Small Cap Growth StrategyJune 2025
Stevanato is a leading provider of specialty glass and plastic packaging for the health care industry, poised for attractive earnings growth driven by a shift to higher margin products and the expansion of biologic drugs.
Read the full thesis
Read every full thesis on Stevanato Group
Unlock all 4 theses — the full reasoning behind what funds are buying, plus unlimited access to the entire archive.
View plans→